Walle A J, Wong G Y, Suthanthiran M, Rubin A L, Stenzel K H, Darzynkiewicz Z
Rogosin Institute, New York Hospital, Cornell University Medical College, New York 10021.
Cytometry. 1988 Mar;9(2):177-82. doi: 10.1002/cyto.990090213.
The DNA and RNA contents of blood mononuclear cell populations of 29 cadaver renal allograft recipients and 49 blood donors (controls) were estimated by acridine orange flow cytometry (AO FCM) to assess their cell cycle status. All patients received azathioprine and prednisone for immunosuppression. The patients represented three clinical categories: clinically stable patients, those with acute rejections (clinically overt or impending), and those with infections. Three cell cycle compartments were analyzed for percentage (%) and RNA content (R) of cells: G0/1, consisting of all cells with diploid DNA content; 2 S.D., consisting of cells with diploid DNA content and RNA content 2 standard deviations above the mean RNA content of controls; and SG2M, consisting of cells with a DNA content higher than that of G0/1 cells. The relative coefficient of variation (rCV) of the DNA distribution of G0/1 cells was also determined. In such cell cycle evaluations, the means of rCV and SG2M% of stable recipients were significantly different from those of blood donors. Multivariate analysis of the variables of the three categories of patients resulted in the tentative formulation of two simple logistic equations: one that differentiates stable patients from those with impending or overt rejections based on 2SD% and another one that distinguishes infected patients from those with impending or overt rejections based on SG2M% and RG0/1.
采用吖啶橙流式细胞术(AO FCM)对29例尸体肾移植受者和49例献血者(对照组)血液单核细胞群的DNA和RNA含量进行评估,以分析其细胞周期状态。所有患者均接受硫唑嘌呤和泼尼松进行免疫抑制。患者分为三个临床类别:临床稳定患者、急性排斥反应患者(临床明显或即将发生排斥反应)以及感染患者。分析了三个细胞周期区室中细胞的百分比(%)和RNA含量(R):G0/1期,由所有具有二倍体DNA含量的细胞组成;2 S.D.期,由具有二倍体DNA含量且RNA含量高于对照组平均RNA含量2个标准差的细胞组成;SG2M期,由DNA含量高于G0/1期细胞的细胞组成。还测定了G0/1期细胞DNA分布的相对变异系数(rCV)。在此类细胞周期评估中,稳定受者的rCV和SG2M%平均值与献血者的显著不同。对三类患者的变量进行多变量分析后,初步建立了两个简单的逻辑方程:一个基于2SD%将稳定患者与即将发生或明显排斥反应的患者区分开来,另一个基于SG2M%和RG0/1将感染患者与即将发生或明显排斥反应的患者区分开来。